Actinium Pharmaceuticals, Inc Share Price
NASDAQ: ATNMHealthcare
Live Actinium Pharmaceuticals, Inc Share Price Chart
O H L
Actinium Pharmaceuticals, Inc Performance Overview
Days Range
▼
$1.19Low
$1.25High
Markets Today
| Previous Close | $1.19 |
|---|---|
| Open | $1.25 |
| Volume | 57,025 |
| Day's Range | $1.19 - $1.25 |
| 52W Range | $0.74 - $1.74 |
| Market Cap | $38.99 M |
Historical Performance
| 1M Returns | +10.19 |
|---|---|
| 3M Returns | +15.53 |
| 6M Returns | +8.18 |
| 1Y Returns | -27.88 |
| 5Y Returns | -84.80 |
| 10Y Returns | -97.60 |
Actinium Pharmaceuticals, Inc Fundamentals
| Market Cap | $38.99 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 3.48 |
| PEG Ratio | N/A |
| Revenue | $90.00 K |
| ROE TTM | -1.67 |
| EPS TTM | $0.36 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.29 |
| EBITDA | $-36.07 M |
| Profit Margin | -37652.22 |
| Market Cap | $38.99 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 3.48 |
| PEG Ratio | N/A |
| Revenue | $90.00 K |
| ROE TTM | -1.67 |
| EPS TTM | $0.36 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 1.29 |
| EBITDA | $-36.07 M |
| Profit Margin | -37652.22 |
Actinium Pharmaceuticals, Inc Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $90.00 K | $0 | $0 | $35.00 M |
| Gross Profit + | $0 | $0 | $90.00 K | $0 | $0 | $35.00 M |
| Operating Income | -$16.64 M | -$7.50 M | -$5.69 M | -$6.41 M | -$5.90 M | $27.57 M |
| EBITDA | -$16.59 M | -$7.14 M | -$5.49 M | -$6.86 M | -$5.87 M | $28.00 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $47.00 K | $362.00 K | $206.00 K | -$442.00 K | $29.00 K | $432.00 K |
| Income Before Tax | -$15.94 M | -$6.88 M | -$5.13 M | -$5.94 M | -$5.52 M | $27.90 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$15.94 M | -$6.88 M | -$5.13 M | -$5.94 M | -$5.52 M | $27.90 M |
| Net Profit Margin | - | - | -5701.11% | - | - | 79.72% |
Actinium Pharmaceuticals, Inc Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $31.00 K | $31.00 K | $31.00 K | $31.00 K | $31.00 K | $31.00 K |
| Reserve & Surplus | -$391.76 M | -$398.64 M | -$403.77 M | -$409.73 M | -$415.27 M | -$387.39 M |
| Non-Current Liabilities | $35.84 M | $35.69 M | $35.53 M | $35.97 M | $35.78 M | $595.00 K |
| Current Liabilities | $7.11 M | $8.31 M | $6.83 M | $7.97 M | $7.35 M | $9.26 M |
| Total Liabilities | $42.95 M | $44.00 M | $42.37 M | $43.94 M | $43.13 M | $9.86 M |
| Fixed Assets | $317.00 K | $271.00 K | $226.00 K | $295.00 K | $268.00 K | $700.00 K |
| Current Assets | $66.46 M | $61.03 M | $54.37 M | $49.38 M | $43.26 M | $37.74 M |
| Total Assets | $68.65 M | $63.02 M | $56.15 M | $51.77 M | $45.44 M | $40.16 M |
Actinium Pharmaceuticals, Inc Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$15.94 M | -$6.88 M | -$5.13 M | -$5.94 M | -$5.52 M | $27.90 M |
| Operating Cash Flow | -$7.57 M | -$5.39 M | -$6.33 M | -$5.29 M | -$5.87 M | -$5.18 M |
| Investing Cash Flow | $0 | $0 | $0 | -$104.00 K | -$2.00 K | -$478.00 K |
| Financing Cash Flow | -$2.00 K | -$3.00 K | -$209.00 K | -$3.00 K | -$3.00 K | -$2.00 K |
| Change in Cash | -$7.58 M | -$5.39 M | -$6.53 M | -$5.39 M | -$5.86 M | -$5.66 M |
Actinium Pharmaceuticals, Inc Return Calculator
The Actinium Pharmaceuticals, Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$1,507
Invested Amount$10,000
Est. Returns$-8,493
About Actinium Pharmaceuticals, Inc
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of targeted radiotherapies using its Antibody Radiation Conjugates (ARCs) platform, which combines monoclonal antibodies with radioisotopes to selectively target and destroy cancer cells. The company's product candidates include Iomab-B, an iodine-131 based radiotherapy for conditioning prior to hematopoietic stem cell transplantation, and Actimab-A, an actinium-225 based radiotherapy in clinical development for acute myeloid leukemia. The company is also advancing additional programs, including Iomab-ACT for cell and gene therapy conditioning and other preclinical candidates targeting solid tumors.
Popular Stocks
FAQs
What is the share price of Actinium Pharmaceuticals, Inc today?
Actinium Pharmaceuticals, Inc (ATNM) share price as of September 18, 2026 is $1.18. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Actinium Pharmaceuticals, Inc?
Yes, Indian Investors can invest in the Actinium Pharmaceuticals, Inc (ATNM) Share by opening an international trading account with Angel One.
How can I purchase Actinium Pharmaceuticals, Inc shares in India?
Purchasing Actinium Pharmaceuticals, Inc (ATNM) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Actinium Pharmaceuticals, Inc (ATNM) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Actinium Pharmaceuticals, Inc?
Yes, you can purchase fractional shares of Actinium Pharmaceuticals, Inc (ATNM) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Actinium Pharmaceuticals, Inc?
The market capitalization of Actinium Pharmaceuticals, Inc on September 18, 2026, is $38.99 M.
In which sector Actinium Pharmaceuticals, Inc belongs?
Actinium Pharmaceuticals, Inc operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Actinium Pharmaceuticals, Inc stocks?
In order to invest in Actinium Pharmaceuticals, Inc (ATNM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
